It was business as usual for the biotech sector last week with highlights including a deal for the acquisition of product rights, encouraging study results and the granting of breakthrough therapy status for an experimental cancer treatment. Here we take a look at all these news in detail. Regado Biosciences saw its shares plunging 58% on news that a data safety monitoring board (DSMB) is … Continue reading Biotech Stocks Roundup: A look at Regado Biosciences, Jazz Pharmaceuticals & Agenus Inc

In this article, we take a look at two stocks which have been in news recently, AcelRx Pharmaceuticals (ACRX) & Nymox Pharmaceuticals (NYMX). Keep an eye out for both these active stocks which have been performing well on the wall street. AcelRx Pharmaceuticals (ACRX) should win FDA approval for the Zalviso pain-killing device on July 27. The Zalviso phase III studies were all well designed … Continue reading Active Biotech Stocks: AcelRx Pharmaceuticals (ACRX) & Nymox Pharmaceuticals (NYMX)

In this article, we take a look at two stocks which have been in news recently, Prana Biotech Ltd (NASDAQ PRAN) & Applied Genetic Corp (NASDAQ AGTC). Keep an eye out for both these active stocks which have been performing well on the wall street. With new recruits coming in for either of them, the two stock would look to reach higher targets. Prana Biotechnology … Continue reading Active Biotech Stocks Prana Biotech Ltd (NASDAQ PRAN) & Applied Genetic Corp (NASDAQ AGTC)

Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII). Both had some major announcements to be made in the past month and the stocks have since shown some very positive upside. Veracyte Inc (NASDAQ VCYT) a molecular diagnostics company pioneering the field of molecular cytology, on 3 July announced that … Continue reading Biotech Stocks to Watch Veracyte Inc. (NASDAQ VCYT) & RXi Corp (NASDAQ RXII)